Response to “Aromatase Inhibitors and Dementia Risk: Putting Safety Into Perspective”

Response to “Aromatase Inhibitors and Dementia Risk: Putting Safety Into Perspective”

Saved in:

Bibliographic Details
Main Authors:	María Teresa Yuste, María Sainz‐Gil, Elisa Escudero, Pedro Marín
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	Pharmacology Research & Perspectives
Online Access:	https://doi.org/10.1002/prp2.70103
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Aromatase Inhibitors and Dementia Risk: Putting Safety Into Perspective
by: Mariam Rizk, et al.
Published: (2025-06-01)

Overall Survival With Palbociclib and Aromatase Inhibitor Versus Aromatase Inhibitor Alone in Older Patients With HR+/HER2− Metastatic Breast Cancer
by: Adam M. Brufsky, et al.
Published: (2025-04-01)

Pharmacokinetics and Bioavailability of Doxycycline Following Parenteral Administration in Rabbits
by: Martínez José, et al.
Published: (2025-03-01)

Aromatase Inhibitor-Related Lower Limb Tendinopathies: Ultrasound is on the Agenda
by: Berkay Yalçınkaya, et al.
Published: (2025-07-01)

Concurrent Arterial and Venous Thromboembolism While Receiving an Aromatase Inhibitor
by: Ibrahim Shahid, et al.
Published: (2024-08-01)

Low Skeletal Muscle Radiodensity Predicts Response to CDK4/6 Inhibitors Plus Aromatase Inhibitors in Advanced Breast Cancer
by: Hyunwook Kim, et al.
Published: (2025-02-01)

Effects of a Multimodal Program on Frailty Syndrome and Psychological Alterations in Breast Cancer Women Treated with Aromatase Inhibitors
by: Pedro Céspedes, et al.
Published: (2025-02-01)

Selective estrogen receptor modulators and aromatase inhibitors in the treatment of functional male hypogonadism
by: Jakub Wydra, et al.
Published: (2025-08-01)

A Case of Erythrocytosis in a Patient Treated with an Aromatase Inhibitor for Breast Cancer
by: Abhinav Iyengar, et al.
Published: (2013-01-01)

Short Stature in Chronic Kidney Disease Treated with Growth Hormone and an Aromatase Inhibitor
by: Susan R. Mendley, et al.
Published: (2015-01-01)

Determination and Disposition of the Aromatase Inhibitor Exemestane in CYP3A-Deficient Mice
by: Hanieh Taheri, et al.
Published: (2025-03-01)

Atrial fibrillation in breast cancer therapy: does tamoxifen confer a lower risk than aromatase inhibitors?
by: Patrick A. Kwaah, et al.
Published: (2025-05-01)

Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting
by: Efthymia Skafida, et al.
Published: (2023-01-01)

Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor‐Associated Musculoskeletal Symptoms in Breast Cancer
by: Nicole M. G. Fleege, et al.
Published: (2025-08-01)

Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment
by: Huda R. M. Rashdan, et al.
Published: (2022-01-01)

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
by: Yuan-Yuan Wu, et al.
Published: (2025-05-01)

Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer
by: Sri Lakshmi Hyndavi Yeruva, et al.
Published: (2015-01-01)

Sex Reversal of Red Tilapia (Oreochromis sp.) by Larval Immersion using Aromatase Inhibitor
by: M. Agus Sudrajat, et al.
Published: (2007-01-01)

Virtual Screening of Apigenin and Luteolin as Natural Aromatase Inhibitors for the Treatment of Breast Cancer Patients
by: Baydaa Hamad Obaid Saleh
Published: (2024-10-01)

THE ROLE OF AROMATASE IN THE DEVELOPMENT OF ENDOMETRIOSIS
by: L. V. Adamyan, et al.
Published: (2017-03-01)

Optimization of abdominal CT based on a model of total risk minimization by putting radiation risk in perspective with imaging benefit
by: Francesco Ria, et al.
Published: (2024-12-01)

Rheumatic aspects of arthralgias associated with aromatase inhibitor therapy (analysis of a clinical case series)
by: A. D. Koltakova, et al.
Published: (2023-02-01)

Estrogen/androgen balance in men with hyperestrogenism normalized by using letrozole of the aromatase inhibitor drug class
by: Z. Sh. Pavlova, et al.
Published: (2022-03-01)

Plasma Proteomics and Metabolomics of Aromatase Inhibitors-Related Musculoskeletal Syndrome in Early Breast Cancer Patients
by: Feng Jing, et al.
Published: (2025-02-01)

A Fast and Accurate Method for the Quantification of Doxycycline in Goat Plasma and Milk by HPLC Using a Fluorescence Detector
by: Martínez José, et al.
Published: (2024-12-01)

Aromatase Activity and Bone Loss in Men
by: Daniela Merlotti, et al.
Published: (2011-01-01)

Aromatase inhibitors therapy and major osteoporotic fracture risk in postmenopausal breast cancer patients: a nationwide real-world cohort study
by: Pin-Han Liu, et al.
Published: (2025-05-01)

Comparative study of the efficacy of tamoxifen and aromatase inhibitors among breast cancer patients at Kenyatta National Hospital
by: Henry Gachoki Macharia, et al.
Published: (2025-08-01)

Impact of a Physical Exercise and Health Education Program on Metabolic Syndrome and Quality of Life in Postmenopausal Breast Cancer Women Undergoing Adjuvant Treatment with Aromatase Inhibitors
by: Pedro Cespedes, et al.
Published: (2024-11-01)

To Reconstruct the Anterior Cruciate Ligament or Not? – Put into Panther Perspective
by: Kristian Thorborg
Published: (2021-06-01)

Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study
by: Alessandro Rossini, et al.
Published: (2020-01-01)

Treatment Modalities for Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS): A Scoping Review of Prospective Treatment Studies
by: Bobo JA, et al.
Published: (2025-04-01)

Putting It Together
by: Anne Cecilie Røsjø Kvammen, et al.
Published: (2024-12-01)

Real-world effectiveness of palbociclib plus an aromatase inhibitor in HR+/HER2− MBC patients living in disadvantaged neighborhoods
by: Filipa Lynce, et al.
Published: (2025-07-01)

Aromatase inhibitors can improve the semen quality of aged roosters by up regulating genes related to steroid hormone synthesis
by: Xuliang Luo, et al.
Published: (2024-12-01)

Lo ponemos en el Tuenti. Comunicación y Educación Superior / We put it in Tuenti. Communication and Higher Education
by: M. Lourdes Hernández Rincón, et al.
Published: (2012-07-01)

Amygdala aromatase controls food intake, reward, and thermoregulation
by: Ivana Maric, et al.
Published: (2025-09-01)

Molecular Bases and Phenotypic Determinants of Aromatase Excess Syndrome
by: Maki Fukami, et al.
Published: (2012-01-01)

Vitreoretinal Traction Syndrome, Nitrituria and Human Epidermal Growth Factor Receptor Negative Might Occur in the Aromatase-Inhibitor Anastrozole Treatment
by: Jie Li, et al.
Published: (2024-01-01)

Effects of the efficacy of the Yi Shen Tiao Gan formula on aromatase inhibitor associated musculoskeletal syndrome: a randomized controlled trial
by: Yan Zhang, et al.
Published: (2025-07-01)